Drug & medication recalls Moderate risk

Morphine Sulfate 4 mg/mL PF Injection recalled over sterility concerns

Recall date
April 11, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Premier Pharmacy Labs Inc recalls Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL…
Recall number
D-0700-2018
FDA classification
Class II
Brand / firm
Premier Pharmacy Labs Inc
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Morphine Sulfate 4 mg/mL PF Injection. 1 mL in a 3ml Sterile Single-Dose Syringe. 8265 Commerical Way Weeki Wachee, FL 34613. NDC 69623-127-10

Get recall alerts

Free email alert whenever Premier Pharmacy Labs Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Premier Pharmacy Labs Inc